EcoDrugPlus

Integrin Beta 3

Ensembl ID : ENSMSIG00000026952
Gene Symbol: ITGB3
1 Cross references
280 Possible Orthologues:

Integrin Beta 5

Ensembl ID : ENSMSIG00000011712
Gene Symbol: ITGB5
1 Cross references
225 Possible Orthologues:

Integrin Beta 6

Ensembl ID : ENSMSIG00000004664
Gene Symbol: ITGB6
1 Cross references
221 Possible Orthologues:

Integrin Beta 7

Ensembl ID : ENSMSIG00000025781
Gene Symbol: ITGB7
1 Cross references
175 Possible Orthologues:

Integrin Beta 8

Ensembl ID : ENSMSIG00000017155
Gene Symbol: ITGB8
1 Cross references
217 Possible Orthologues:

Intercellular Adhesion Molecule 1

Ensembl ID : ENSMSIG00000017165
Gene Symbol: ICAM1
1 Cross references
108 Possible Orthologues:

Interleukin 5

Ensembl ID : ENSMSIG00000017660
Gene Symbol: IL5
1 Cross references
106 Possible Orthologues:

Interleukin 6

Ensembl ID : ENSMSIG00000012630
Gene Symbol: IL6
1 Cross references
177 Possible Orthologues:

Interleukin-1 Receptor-Associated Kinase 4

Ensembl ID : ENSMSIG00000020968
Gene Symbol: IRAK4
1 Cross references
217 Possible Orthologues:

Isocitrate Dehydrogenase 1 (Nadp+), Soluble

Ensembl ID : ENSMSIG00000009702
Gene Symbol: IDH1
1 Cross references
247 Possible Orthologues:

Isocitrate Dehydrogenase 2 (Nadp+), Mitochondrial

Ensembl ID : ENSMSIG00000017730
Gene Symbol: IDH2
1 Cross references
276 Possible Orthologues:

Kallikrein B, Plasma 1

Ensembl ID : ENSMSIG00000027129
Gene Symbol: KLKB1
1 Cross references
221 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).